NDC 86136-017 - Nobatol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86136-017
- Package NDCs from labels
- 86136-017-10, 86136-017-50
- Manufacturer
- MWI/VetOne
- Effective date
- 2023-06-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nobatol - MWI/VetOne | MWI/VetOne | 2023-06-08 | PRESCRIPTION ANIMAL DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phenobarbital | PHENOBARBITAL | Bryant Ranch Prepack | 9ad46e1e-4de6-4d30-a2cf-149fcffb5e33 | 2024-10-04 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Proficient Rx LP | 6b5ca781-50a9-4e89-8184-831c7c2936b2 | 2024-10-01 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Bryant Ranch Prepack | d16f6911-f218-41ab-86c6-f3cceaf315e3 | 2024-08-20 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Par Health USA, LLC | 069b92ce-0061-4724-8c25-08d8596770a2 | 2024-08-20 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Hikma Pharmaceuticals USA Inc. | 8f02e85a-6dca-467d-b2bf-ab2f9fa9ef3b | 2024-07-30 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Bryant Ranch Prepack | 2c238b77-6806-44af-9a66-fd871eaddfc0 | 2024-03-28 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Proficient Rx LP | 7d6516be-285b-41be-a1f3-8c9ad8857316 | 2024-03-01 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Bryant Ranch Prepack | b844862f-2c1c-46aa-b113-ee74c20534b9 | 2024-02-07 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Bryant Ranch Prepack | e1709a49-ee44-4679-9a57-a7ea85a78ab7 | 2024-01-11 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Bryant Ranch Prepack | a6ae0875-77dd-48a7-b1bd-dc6f6bd7b2ab | 2024-01-11 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Bryant Ranch Prepack | ee6c3196-becf-439d-9e22-70d82bd94365 | 2024-01-11 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Clinical Solutions Wholesale, LLC | b0b862b9-235d-4a7c-ac4a-80d41c5a1b8b | 2024-01-09 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Clinical Solutions Wholesale, LLC | 8483f082-131d-4218-81d7-61c716af65b5 | 2024-01-09 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Bryant Ranch Prepack | 4c3a219f-39ff-4fdc-9e88-12fdd7c32019 | 2023-12-08 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Westminster Pharmaceuticals, LLC | 0ca8847d-1966-47a0-995e-a5c0d2fd699d | 2023-10-12 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Bryant Ranch Prepack | b099ff66-da3d-47a1-b721-8b5b5e4a13ba | 2023-09-13 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Westminster Pharmaceuticals, LLC | 4e70d33b-82f3-4a8e-a35b-ee658b3e0ab1 | 2023-09-13 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Bryant Ranch Prepack | ee1fe3ac-7a2e-4133-90a2-1d8dc0552e74 | 2023-08-29 | Warnings, Adverse reactions | YQE403BP4D |
| Phenobarbital | PHENOBARBITAL | Bryant Ranch Prepack | 4c2442af-82f3-4a16-bd2b-630c6f081d3e | 2023-02-27 | Warnings, Adverse reactions | YQE403BP4D |
| PHENOBARBITAL | PHENOBARBITAL | QUAGEN PHARMACEUTICALS LLC | 7e6853a4-478d-40e3-b041-4cff02a74c8c | 2023-02-16 | Warnings, Adverse reactions | YQE403BP4D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.